OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunogenicity and safety of the BNT162b2 mRNA COVID‐19 vaccine in haematopoietic stem cell transplantation recipients
Noga Shem‐Tov, Ronit Yerushalmi, Ivetta Danylesko, et al.
British Journal of Haematology (2021) Vol. 196, Iss. 4, pp. 884-891
Open Access | Times Cited: 65
Noga Shem‐Tov, Ronit Yerushalmi, Ivetta Danylesko, et al.
British Journal of Haematology (2021) Vol. 196, Iss. 4, pp. 884-891
Open Access | Times Cited: 65
Showing 1-25 of 65 citing articles:
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
Ainsley Ryan Yan Bin Lee, Shi Yin Wong, Louis Yi Ann Chai, et al.
BMJ (2022), pp. e068632-e068632
Open Access | Times Cited: 390
Ainsley Ryan Yan Bin Lee, Shi Yin Wong, Louis Yi Ann Chai, et al.
BMJ (2022), pp. e068632-e068632
Open Access | Times Cited: 390
COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
Annika Fendler, Elisabeth G.E. de Vries, Corine H. GeurtsvanKessel, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 6, pp. 385-401
Open Access | Times Cited: 178
Annika Fendler, Elisabeth G.E. de Vries, Corine H. GeurtsvanKessel, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 6, pp. 385-401
Open Access | Times Cited: 178
Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9)
Simone Cesaro, Per Ljungman, Małgorzata Mikulska, et al.
Leukemia (2022) Vol. 36, Iss. 6, pp. 1467-1480
Open Access | Times Cited: 105
Simone Cesaro, Per Ljungman, Małgorzata Mikulska, et al.
Leukemia (2022) Vol. 36, Iss. 6, pp. 1467-1480
Open Access | Times Cited: 105
International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update
Seth J. Rotz, Neel S. Bhatt, Betty K. Hamilton, et al.
Transplantation and Cellular Therapy (2024) Vol. 30, Iss. 4, pp. 349-385
Open Access | Times Cited: 19
Seth J. Rotz, Neel S. Bhatt, Betty K. Hamilton, et al.
Transplantation and Cellular Therapy (2024) Vol. 30, Iss. 4, pp. 349-385
Open Access | Times Cited: 19
Vaccination of Adults With Cancer: ASCO Guideline
Mini Kamboj, Kari Bohlke, Deana M. Baptiste, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 14, pp. 1699-1721
Closed Access | Times Cited: 17
Mini Kamboj, Kari Bohlke, Deana M. Baptiste, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 14, pp. 1699-1721
Closed Access | Times Cited: 17
Vaccine schedule recommendations and updates for patients with hematologic malignancy post‐hematopoietic cell transplant or CAR T‐cell therapy
Gemma Reynolds, Victoria Hall, Benjamin W. Teh
Transplant Infectious Disease (2023) Vol. 25, Iss. S1
Open Access | Times Cited: 24
Gemma Reynolds, Victoria Hall, Benjamin W. Teh
Transplant Infectious Disease (2023) Vol. 25, Iss. S1
Open Access | Times Cited: 24
Safety and Immunogenicity After a Three-Dose SARS-CoV-2 Vaccine Schedule in Allogeneic Stem Cell Transplant Recipients
Muneyoshi Kimura, Victor H. Ferreira, Sagar Kothari, et al.
Transplantation and Cellular Therapy (2022) Vol. 28, Iss. 10, pp. 706.e1-706.e10
Open Access | Times Cited: 35
Muneyoshi Kimura, Victor H. Ferreira, Sagar Kothari, et al.
Transplantation and Cellular Therapy (2022) Vol. 28, Iss. 10, pp. 706.e1-706.e10
Open Access | Times Cited: 35
Serologic response and safety of COVID-19 vaccination in HSCT or CAR T-cell recipients: a systematic review and meta-analysis
Chenghao Ge, Kelei Du, Mingjie Luo, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 24
Chenghao Ge, Kelei Du, Mingjie Luo, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 24
Risk factors for a severe disease course in children with SARS-COV-2 infection following hematopoietic cell transplantation in the pre-Omicron period: a prospective multinational Infectious Disease Working Party from the European Society for Blood and Marrow Transplantation group (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH) study
Diana Averbuch, Rafael de la Cámara, Gloria Tridello, et al.
Bone Marrow Transplantation (2023) Vol. 58, Iss. 5, pp. 558-566
Open Access | Times Cited: 14
Diana Averbuch, Rafael de la Cámara, Gloria Tridello, et al.
Bone Marrow Transplantation (2023) Vol. 58, Iss. 5, pp. 558-566
Open Access | Times Cited: 14
International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update
Seth J. Rotz, Neel S. Bhatt, Betty K. Hamilton, et al.
Bone Marrow Transplantation (2024) Vol. 59, Iss. 6, pp. 717-741
Closed Access | Times Cited: 4
Seth J. Rotz, Neel S. Bhatt, Betty K. Hamilton, et al.
Bone Marrow Transplantation (2024) Vol. 59, Iss. 6, pp. 717-741
Closed Access | Times Cited: 4
Efficacy of COVID-19 Vaccines in Patients with Hematological Malignancy Compared to Healthy Controls: A Systematic Review and Meta-analysis
Anindita Das Barshan, Emilie Louise Akiko Matsumoto-Takahashi
JMA Journal (2024) Vol. 7, Iss. 2, pp. 153-171
Open Access | Times Cited: 4
Anindita Das Barshan, Emilie Louise Akiko Matsumoto-Takahashi
JMA Journal (2024) Vol. 7, Iss. 2, pp. 153-171
Open Access | Times Cited: 4
Evaluation of Immunogenicity and Safety of Vero Cell-Derived Inactivated COVID-19 Vaccine in Older Patients with Hypertension and Diabetes Mellitus
Yuntao Zhang, Haiping Chen, Jun Lv, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1020-1020
Open Access | Times Cited: 19
Yuntao Zhang, Haiping Chen, Jun Lv, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1020-1020
Open Access | Times Cited: 19
COVID-19 and HSCT (Hematopoietic stem cell transplant)
Lynne Strasfeld
Best Practice & Research Clinical Haematology (2022) Vol. 35, Iss. 3, pp. 101399-101399
Open Access | Times Cited: 19
Lynne Strasfeld
Best Practice & Research Clinical Haematology (2022) Vol. 35, Iss. 3, pp. 101399-101399
Open Access | Times Cited: 19
Impaired humoral and cellular response to primary COVID ‐19 vaccination in patients less than 2 years after allogeneic bone marrow transplant
Sam M. Murray, Maria Chiara Barbanti, Cori Campbell, et al.
British Journal of Haematology (2022) Vol. 198, Iss. 4, pp. 668-679
Open Access | Times Cited: 18
Sam M. Murray, Maria Chiara Barbanti, Cori Campbell, et al.
British Journal of Haematology (2022) Vol. 198, Iss. 4, pp. 668-679
Open Access | Times Cited: 18
COVID-19 Vaccination in Patients With Cancer and Patients Receiving HSCT or CAR-T Therapy: Immune Response, Real-World Effectiveness, and Implications for the Future
Victoria Hall, Benjamin W. Teh
The Journal of Infectious Diseases (2023) Vol. 228, Iss. Supplement_1, pp. S55-S69
Open Access | Times Cited: 11
Victoria Hall, Benjamin W. Teh
The Journal of Infectious Diseases (2023) Vol. 228, Iss. Supplement_1, pp. S55-S69
Open Access | Times Cited: 11
COVID‐19 after hematopoietic cell transplantation and chimeric antigen receptor (CAR)‐T‐cell therapy
Eleftheria Kampouri, Joshua A. Hill, M. Veronica Dioverti
Transplant Infectious Disease (2023) Vol. 25, Iss. S1
Closed Access | Times Cited: 10
Eleftheria Kampouri, Joshua A. Hill, M. Veronica Dioverti
Transplant Infectious Disease (2023) Vol. 25, Iss. S1
Closed Access | Times Cited: 10
The Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Japanese Patients after Allogeneic Stem Cell Transplantation
Marika Watanabe, Kimikazu Yakushijin, Yohei Funakoshi, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 158-158
Open Access | Times Cited: 17
Marika Watanabe, Kimikazu Yakushijin, Yohei Funakoshi, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 158-158
Open Access | Times Cited: 17
Allogeneic hematopoietic stem cell transplantation in the COVID-19 era
Jonathan Bordat, Sébastien Maury, Mathieu Leclerc
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Jonathan Bordat, Sébastien Maury, Mathieu Leclerc
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Predictors of Covid-19 Vaccination Response After In-Vivo T-Cell–Depleted Stem Cell Transplantation
Ok-Kyong Chaekal, Alexandra Gomez-Arteaga, Zhengming Chen, et al.
Transplantation and Cellular Therapy (2022) Vol. 28, Iss. 9, pp. 618.e1-618.e10
Open Access | Times Cited: 15
Ok-Kyong Chaekal, Alexandra Gomez-Arteaga, Zhengming Chen, et al.
Transplantation and Cellular Therapy (2022) Vol. 28, Iss. 9, pp. 618.e1-618.e10
Open Access | Times Cited: 15
A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies
Maryam Noori, Shadi Azizi, Farhan Abbasi Varaki, et al.
International Immunopharmacology (2022) Vol. 110, pp. 109046-109046
Open Access | Times Cited: 14
Maryam Noori, Shadi Azizi, Farhan Abbasi Varaki, et al.
International Immunopharmacology (2022) Vol. 110, pp. 109046-109046
Open Access | Times Cited: 14
Frequently Asked Questions on Coronavirus Disease 2019 Vaccination for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Recipients From the American Society for Transplantation and Cellular Therapy and the American Society of Hematology
Fareed Khawaja, Genovefa A. Papanicolaou, Sanjeet Dadwal, et al.
Transplantation and Cellular Therapy (2022) Vol. 29, Iss. 1, pp. 10-18
Open Access | Times Cited: 14
Fareed Khawaja, Genovefa A. Papanicolaou, Sanjeet Dadwal, et al.
Transplantation and Cellular Therapy (2022) Vol. 29, Iss. 1, pp. 10-18
Open Access | Times Cited: 14
Reduced Antibodies and Innate Cytokine Changes in SARS-CoV-2 BNT162b2 mRNA Vaccinated Transplant Patients With Hematological Malignancies
Cristina Bergamaschi, Maria Pagoni, Margherita Rosati, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Cristina Bergamaschi, Maria Pagoni, Margherita Rosati, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Predictors of impaired antibody response after SARS‐CoV ‐2 mRNA vaccination in hematopoietic cell transplant recipients: A Japanese multicenter observational study
Yasuo Mori, Naoyuki Uchida, Takuya Harada, et al.
American Journal of Hematology (2022) Vol. 98, Iss. 1, pp. 102-111
Open Access | Times Cited: 12
Yasuo Mori, Naoyuki Uchida, Takuya Harada, et al.
American Journal of Hematology (2022) Vol. 98, Iss. 1, pp. 102-111
Open Access | Times Cited: 12
Third BNT162b2 mRNA SARS-CoV-2 Vaccine Dose Significantly Enhances Immunogenicity in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
Israel Henig, Jonathan Isenberg, Dana Yehudai‐Ofir, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 775-775
Open Access | Times Cited: 6
Israel Henig, Jonathan Isenberg, Dana Yehudai‐Ofir, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 775-775
Open Access | Times Cited: 6
Robust spike-specific CD4+ and CD8+ T cell responses in SARS-CoV-2 vaccinated hematopoietic cell transplantation recipients: a prospective, cohort study
Lorenzo Federico, Tor Henrik Anderson Tvedt, Murat Gainullin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Lorenzo Federico, Tor Henrik Anderson Tvedt, Murat Gainullin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
